Panakès Partners
Also known as Panakès Partners SGR, Panakes Partners, Panakes Partners SGR S.p.A., Panakès
Milan life-sciences venture capital SGR and EuVECA manager (2015) investing in early-stage medtech, diagnostics and biotech companies, mainly in Europe; €250M under management (2026).
- HEADQUARTERS
- Milan, Italy
- FOUNDED
- 2015
- AUM
- €250M (2026)
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 8 people
FOCUS
- STAGES
- SeedSeries ASeries B
- ASSET MIX
- Venture capital
- GEOGRAPHY
- EuropeItaly
WHAT IT IS
VC Fund. A fund manager investing capital raised from limited partners into startups.
ABOUT
Panakès Partners SGR is a Milan asset management company registered with the Banca d'Italia as an AIF manager and EuVECA manager, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni. It invests in early-stage start-ups and SMEs developing medical technologies, diagnostics and therapeutics, mainly across Europe, through Panakès Fund and Panakès Fund Purple. In July 2026 it reached a first close of BII Catalyst Fund I for Italy, an early-stage therapeutics fund anchored by Lazio Innova (€20M) and Novo Holdings, which it manages. It reported €250M under management in July 2026.
INVESTMENT THESIS
Backs life-sciences companies answering unmet medical needs — medical devices, in-vitro and in-vivo diagnostics, digital and robotic surgery, and biotech therapies — at early stage, adding clinical and industrial networks to capital.
PORTFOLIO (14)
- HealthTech
- HealthTech
- Biotech & Life Sciences
- HealthTech
- Biotech & Life Sciences
- HealthTech
- Biotech & Life Sciences
- HealthTech
- HealthTech
- HealthTech
- Biotech & Life Sciences
- HealthTech
- HealthTech
- HealthTech
TEAM
LINKS
FAQ
Panakès Partners is a VC fund based in Milan, Italy, founded in 2015.
Yes. Panakès Partners invests directly in private companies.
Panakès Partners invests at Seed, Series A and Series B stages in HealthTech and Biotech & Life Sciences.
Key people at Panakès Partners include Fabrizio Landi (Founder and Managing Partner), Alessio Beverina (Founder and Managing Partner), Diana Saraceni (Founder and Managing Partner) and Barbara Castellano (Partner).
Panakès Partners's investments include Endovascular Engineering, Alesi Surgical, Aileens Pharma, CarThera, Complement Therapeutics, Deepull, DISCO Pharmaceuticals and Echolight, among others.
The most recent publicly reported investment by Panakès Partners is Endovascular Engineering (E2) (Series C ($80M, existing investor)), announced in Apr 2026.
Panakès Partners states that it accepts submissions through its official contact page.
Yes. Panakès Partners manages capital from outside investors.